Governor Glenn Youngkin announced a landmark partnership with AstraZeneca, Eli Lilly and Company, and Merck that commits up to $120 million of private ...

Merck & Company ( ($MRK) ) has released its Q3 earnings. Here is a breakdown of the information Merck & Company presented to its investors. Merck ...

Compared to its lackluster second quarter performance, Merck rallied somewhat in the third quarter of 2025. Revenue and ...

The company's outlook for the rest of the year was rosier than in the previous quarter, when it announced a cost-cutting plan ...

Get the latest on Merck's Q3 2025 earnings, new drug launches, and Verona Pharma acquisition. Discover key growth drivers and financial outlook.

While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.

Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life ...

As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...

The Board of Directors of Jersey City-based Organon has appointed company executive vice president and head of manufacturing & supply ...

Some four years into its run as an independent women’s health outfit, Organon is parting ways with its first CEO after an ...

Organon said its chief executive, Kevin Ali, has stepped down following an internal investigation into sales practices for the company's Nexplanon birth-control implant.

Organon said on Monday CEO Kevin Ali will resign from his role, after an internal investigation into sales of its Nexplanon ...